Oncogenex Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Oncogenex Pharmaceuticals Inc
TickerACHV
CIK #0000949858
CUSIP004468104
SectorLife Sciences - In Vitro & In Vivo Diagnostic Substances
Address1522 217th Place SE, Bothell, WA 98021
Source [EDGAR]
CIK Filing 2011 - 2025
[0000949858] 10-K
[0000949858] 10-Q
[0000949858] 3
[0000949858] 4
[0000949858] 5
[0000949858] 8-K
[0000949858] D
[0000949858] SC 13D
[0000949858] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Alyeska Investment Group LP Achieve Life Sciences Inc [2025-08-14] 0.0
Vanguard Group Inc Achieve Life Sciences Inc [2024-11-04] 5.65
BlackRock Inc Achieve Life Sciences Inc [2024-10-25] 6.0
Propel Bio Management LLC Achieve Life Sciences Inc [2024-05-17] 6.81
Franklin Resources Inc Achieve Life Sciences Inc [2024-03-11] 12.0
Callahan Patrick J III Achieve Life Sciences Inc [2024-02-27] 0.9
Dialectic Capital Management LP Achieve Life Sciences Inc [2023-04-18] 19.68
Dialectic Capital Management LP Achieve Life Sciences Inc [2023-01-20] 19.5
Contrarian Achieve SPV LP Achieve Life Sciences Inc [2022-11-28] 7.369
Dialectic Capital Management LP Achieve Life Sciences Inc [2022-11-21] 19.5
SVB Financial Group Achieve Life Sciences Inc [2021-12-29] 14.5
Francis Capital Management LLC Achieve Life Sciences Inc [2021-01-07] 5.0
Packer Paul Achieve Life Sciences Inc [2020-12-04] 5.8
Pura Vida Investments LLC Achieve Life Sciences Inc [2019-12-27] 7.79
CVI Investments Inc Achieve Life Sciences Inc [2019-12-26] 0.9
Adamas Health Care Fund Achieve Life Sciences Inc [2019-05-28] 5.37
UBS Group AG Achieve Life Sciences Inc [2019-02-14] 6.74
SIO Capital Management LLC Achieve Life Sciences Inc [2019-02-14] 8.89
Armistice Capital LLC Achieve Life Sciences Inc [2018-10-11] 7.6
Hirschman Orin Achieve Life Sciences Inc [2018-07-03] 7.3
Sabby Management LLC Achieve Life Sciences Inc [2018-06-19] 6.49
Schacter Robert Achieve Life Sciences Inc [2017-08-11] 0.0
Stewart Richard Alistair Achieve Life Sciences Inc [2017-08-11] 19.4
Clarke Anthony Achieve Life Sciences Inc [2017-08-11] 6.6
Martell Ron Achieve Life Sciences Inc [2017-08-11] 0.0
Biotechnology Value Fund L P Oncogenex Pharmaceuticals Inc [2014-12-12] 2.98
Sabby Management LLC Oncogenex Pharmaceuticals Inc [2014-11-07] 4.15
Great Point Partners LLC Oncogenex Pharmaceuticals Inc [2014-07-07] 0.99
FMR LLC Oncogenex Pharmaceuticals Inc [2012-04-10] 0.0
Tang Capital Partners LP Oncogenex Pharmaceuticals Inc [2012-03-22] 5.8
BlackRock Inc Oncogenex Pharmaceuticals Inc [2012-02-09] 5.78
Form 3/4/5 Filer 2011 - 2025
Phelan Nancy R.
Achieve Life Sciences Inc
Slaoui Kristen B.
Sellig Thomas
Martell Bridget A
King Thomas Braxton
Duty Stuart
Oki Mark K
Stewart Richard Alistair
Wan Jerry
Xinos Jaime
Jacobs Cindy
Bencich John
Himes Vaughn B
SVB Innovation Credit Partners VIII, LLC
SVB Innovation Credit Partners VIII-A, LLC
SVB Innovation Credit Fund VIII, L.P.
SVB Financial Group
Innovation Credit Fund VIII-A, L.P.
Dialectic Capital Management LP
Dialectic Partners, LLC
Fichthorn John
Dialectic LS Manager LLC
Dialectic Life Sciences SPV LLC
Moyes Jay M
Joseph Donald
Mattingly Martin A
Clarke Anthony
Parker H Stewart
Cormack Scott Daniel
Armistice Capital Master Fund Ltd.
Boyd Steven
Armistice Capital LLC
Schacter Robert
Goldstein Jack
Smith David V
Clendeninn Neil James
Wyrick Susan D.
Griffin Michelle Renee
Lawrence Cameron William
Form 13F Holdings
Firm Period DFND Voting Shares
Propel Bio Management LLC [2025-06-30] DFND 3,601,913 6,153,091
Franklin Resources Inc [2025-06-30] DFND 4,459,014 4,459,014
Alyeska Investment Group LP [2025-06-30] SOLE 3,504,333 3,504,333
Vanguard Group Inc [2025-06-30] SOLE 0 2,135,069
Clearline Capital LP [2025-06-30] SOLE 1,326,259 1,326,259
Simplify Asset Management Inc [2025-06-30] SOLE 1,184,512 1,184,512
Hudson Bay Capital Management LP [2025-06-30] SOLE 1,173,532 1,173,532
Heights Capital Management Inc [2025-06-30] OTR 989,509 989,509
Nantahala Capital Management LLC [2025-06-30] SOLE 898,885 898,885
Millennium Management LLC [2025-06-30] SOLE 386,200 386,200
Geode Capital Management LLC [2025-06-30] DFND 362,200 362,200
Stonepine Capital Management LLC [2025-06-30] SOLE 333,333 333,333
BlackRock, Inc. [2025-06-30] SOLE 314,699 314,699
Raymond James Financial Inc [2025-06-30] DFND 0 295,058
Shay Capital LLC [2025-06-30] SOLE 292,647 292,647
LPL Financial LLC [2025-06-30] SOLE 0 255,833
Long Focus Capital Management LLC [2025-06-30] SOLE 248,099 248,099
Northern Trust Corp [2025-06-30] DFND 215,845 215,845
Caption Management LLC [2025-06-30] SOLE 200,000 200,000
State Street Corp [2025-06-30] DFND 157,884 157,884
Highbridge Capital Management LLC [2025-06-30] SOLE 0 132,937
Royal Bank of Canada [2025-06-30] DFND 117,934 117,934
Y-Intercept (Hong Kong) Ltd [2025-06-30] SOLE 116,409 116,409
Morgan Stanley [2025-06-30] DFND 103,384 106,297
Qube Research & Technologies Ltd [2025-06-30] SOLE 102,581 102,581
Alpine Global Management, LLC [2025-06-30] SOLE 100,000 100,000
UBS Group AG [2025-06-30] DFND 84,914 84,914
Susquehanna International Group LLP [2025-06-30] OTR 72,715 83,315
Jane Street Group LLC [2025-06-30] DFND 70,452 70,452
Brevan Howard Capital Management LP [2025-06-30] DFND 64,348 64,348
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com